Status: Not yet recruiting
The Clinical Research of Traditional Chinese Medicine Compound Formulas
To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.
Participants needed: 100
Trial details
Phase: Phase 4Age: 18-65Biological sex: AllType: InterventionalSponsor: The Fourth Affiliated Hospital of Zhejiang University School of MedicineUpdated: Sep 4, 2025Locations: 1
Eligibility criteria
Fulfillment of western medical diagnostic criteria requiring renal ischemia-repe... [+3]
Patients with stage 4 or 5 renal insufficiency or patients with acute renal fail... [+9]